|
| |
| | | 68824 | | 21.09.2023 | | Pfizer AG | | | | | | | 20.09.2028 | | | | | | | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Atgam 250 mg/5 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Immunoglobulinum Anti-T Limphocytorum ex Equus 50 mg) | L04AA03 | |
|
|
|
